National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 9) (PB 98 of 2016) (Cth)
PB 98 of 2016
National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 9)
National Health Act 1953
I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Determination under section 85B of the National Health Act 1953.
Dated 28th November 2016
PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 9).
(2) This Instrument may also be cited as PB 98 of 2016.
2 Commencement
This Instrument commences on 1 December 2016.
3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1]Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol
omit from the column headed “Claimed Price”: 4.41 substitute: 8.02
[2]Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol
omit:
| Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Fosamax Plus 70 mg/140 mcg | 4 | 4.06 | 4.41 |
substitute:
| Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Dronalen Plus | 4 | 4.06 | 6.02 |
| Fosamax Plus 70 mg/140 mcg | 4 | 4.06 | 8.02 |
[3]Schedule 1, entry for Alendronic acid with colecalciferol and calcium
omit:
| Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral | Fosamax Plus D-Cal | 4 | 4.06 | 4.40 |
substitute:
| Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral | Dronalen Plus D-Cal | 1 | 4.06 | 10.02 |
| Fosamax Plus D-Cal | 1 | 4.06 | 12.02 |
[4]Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity: 100]
omit from the column headed “Determined Price”: 1.84 substitute: 2.26
[5]Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity: 200]
omit from the column headed “Claimed Price”: 6.91 substitute: 7.75
[6]Schedule 1, entry for Allopurinol in the form Tablet 300 mg
(a) omit from the column headed “Determined Price”: 2.16 substitute: 3.27
(b) omit from the column headed “Claimed Price”: 5.39 substitute: 6.51
[7]Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
(a) omit from the column headed “Determined Price”: 0.62 substitute: 1.30
(b) omit from the column headed “Claimed Price”: 3.87 substitute: 4.55
[8]Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
(a) omit from the column headed “Determined Price”: 1.24 substitute: 1.60
(b) omit from the column headed “Claimed Price”: 4.73 substitute: 5.10
[9]Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 0.55 substitute: 1.28
(b) omit from the column headed “Claimed Price”: 3.77 substitute: 4.50
Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 0.80 substitute: 1.59
(b) omit from the column headed “Claimed Price”: 4.11 substitute: 4.90
Schedule 1, entry for Amoxycillin in the form Tablet 1 g (as trihydrate)
(a) omit from the column headed “Determined Price”: 1.27 substitute: 1.47
(b) omit from the column headed “Claimed Price”: 1.61 substitute: 2.47
Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
(a) omit from the column headed “Determined Price”: 1.11 substitute: 1.60
(b) omit from the column headed “Claimed Price”: 4.32 substitute: 4.81
Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
(a) omit from the column headed “Determined Price”: 1.59 substitute: 1.90
(b) omit from the column headed “Claimed Price”: 6.09 substitute: 6.40
Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
(a) omit from the column headed “Determined Price”: 1.81 substitute: 2.30
(b) omit from the column headed “Claimed Price”: 6.34 substitute: 6.83
Schedule 1, entry for Betaxolol
omit from the column headed “Claimed Price”: 9.62 substitute: 11.18
Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg
omit from the column headed “Claimed Price”: 10.93 substitute: 12.94
Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg
omit from the column headed “Claimed Price”: 13.01 substitute: 15.01
Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg
omit from the column headed “Claimed Price”: 15.61 substitute: 17.61
Schedule 1, entry for Brinzolamide
omit from the column headed “Claimed Price”: 15.35 substitute: 17.67
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg
omit from the column headed “Claimed Price”: 2.14 substitute: 2.47
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg
omit from the column headed “Claimed Price”: 3.34 substitute: 3.75
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg
omit from the column headed “Claimed Price”: 6.95 substitute: 7.28
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg
omit from the column headed “Claimed Price”: 8.10 substitute: 12.72
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 7.74 substitute: 8.15
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 8.95 substitute: 13.89
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
omit from the column headed “Claimed Price”: 9.41 substitute: 14.73
Schedule 1, entry for Captopril in the form Tablet 12.5 mg
omit from the column headed “Claimed Price”: 6.65 substitute: 7.26
Schedule 1, entry for Captopril in the form Tablet 25 mg [Brand: Capoten]
omit from the column headed “Claimed Price”: 8.20 substitute: 10.18
Schedule 1, entry for Captopril in the form Tablet 25 mg [Brand: Zedace]
omit from the column headed “Claimed Price”: 8.26 substitute: 8.86
Schedule 1, entry for Captopril in the form Tablet 50 mg [Brand: Capoten]
omit from the column headed “Claimed Price”: 12.58 substitute: 14.42
Schedule 1, entry for Captopril in the form Tablet 50 mg [Brand: Zedace]
omit from the column headed “Claimed Price”: 13.30 substitute: 13.91
Schedule 1, entry for Carbamazepine in the form Tablet 100 mg
(a) omit from the column headed “Determined Price”: 4.88 substitute: 5.47
(b) omit from the column headed “Claimed Price”: 6.26 substitute: 6.86
Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 2.17 substitute: 3.11
(b) omit from the column headed “Claimed Price”: 6.91 substitute: 7.85
Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
(a) omit from the column headed “Determined Price”: 2.33 substitute: 3.31
(b) omit from the column headed “Claimed Price”: 7.27 substitute: 8.25
Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)
(a) omit from the column headed “Determined Price”: 0.81 substitute: 1.59
(b) omit from the column headed “Claimed Price”: 4.31 substitute: 5.09
Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)
(a) omit from the column headed “Determined Price”: 1.46 substitute: 1.73
(b) omit from the column headed “Claimed Price”: 6.55 substitute: 6.82
Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 0.97 substitute: 1.82
(b) omit from the column headed “Claimed Price”: 4.83 substitute: 5.68
Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 1.45 substitute: 2.10
(b) omit from the column headed “Claimed Price”: 6.74 substitute: 7.39
Schedule 1, entry for Ciprofloxacin in the form Eye drops 3 mg (as hydrochloride) per mL, 5 mL
omit from the column headed “Claimed Price”: 10.39 substitute: 10.95
Schedule 1, entry for Citalopram in the form Tablet 20 mg (as hydrobromide)
omit from the column headed “Claimed Price”: 6.29 substitute: 8.15
Schedule 1, entry for Clarithromycin
(a) omit from the column headed “Determined Price”: 2.47 substitute: 2.75
(b) omit from the column headed “Claimed Price”: 5.73 substitute: 6.00
Schedule 1, entry for Clomipramine
omit from the column headed “Claimed Price”: 7.77 substitute: 9.63
Schedule 1, entry for Codeine with paracetamol
(a) omit
| Codapane Forte | 20 | 0.74 | 0.92 |
Schedule 1, entry for Codeine with paracetamol [Brand: Panadeine Forte]
(a) omit from the column headed “Determined Price”: 0.74 substitute: 1.26
(b) omit from the column headed “Claimed Price”: 2.69 substitute: 3.21
Schedule 1, entry for Diazepam
(a) omit from the column headed “Determined Price”: 1.03 substitute: 1.29
(b) omit from the column headed “Claimed Price”: 3.07 substitute: 3.33
Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
omit from the column headed “Claimed Price”: 2.70 substitute: 3.16
Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
omit from the column headed “Claimed Price”: 4.45 substitute: 5.38
Schedule 1, after entry for Digoxin in the form Tablet 250 micrograms
insert in the columns in the order indicated:
| Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | 30 | 6.25 | 8.02 |
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | 30 | 8.45 | 10.22 | |
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | 30 | 11.08 | 12.84 | |
| Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | 90 | 5.64 | 7.40 | |
| Vasocardol | 90 | 5.64 | 7.40 |
Schedule 1, entry for Doxycycline
substitute:
| Doxycycline | Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | 7 | 1.36 | 4.11 |
| Mayne Pharma Doxycycline | 7 | 1.36 | 2.79 | |||
| Doryx | 21 | - | 12.45 | |||
| Mayne Pharma Doxycycline | 21 | - | 7.07 | |||
| Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | 25 | 2.17 | 6.83 | |
| Mayne Pharma Doxycycline | 25 | 2.17 | 4.58 |
Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
omit from the column headed “Claimed Price”: 6.92 substitute: 7.53
Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
omit from the column headed “Claimed Price”: 7.82 substitute: 8.42
Schedule 1, after entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
insert in the columns in the order indicated:
| Enalapril with Hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Renitec Plus 20/6 | 30 | 5.66 | 9.99 |
Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
omit from the column headed “Claimed Price”: 7.99 substitute: 9.85
Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
omit from the column headed “Claimed Price”: 8.33 substitute: 10.19
Schedule 1, entry for Frusemide in the form Tablet 20 mg
(a) omit from the column headed “Determined Price”: 0.62 substitute: 0.78
(b) omit from the column headed “Claimed Price”: 1.30 substitute: 1.46
Schedule 1, entry for Frusemide in the form Tablet 40 mg
(a) omit from the column headed “Determined Price”: 1.13 substitute: 1.56
(b) omit from the column headed “Claimed Price”: 2.85 substitute: 3.28
Schedule 1, entry for Glimepiride in the form Tablet 1 mg
omit from the column headed “Claimed Price”: 2.74 substitute: 2.98
Schedule 1, entry for Glimepiride in the form Tablet 2 mg
omit from the column headed “Claimed Price”: 3.51 substitute: 3.75
Schedule 1, entry for Glimepiride in the form Tablet 3 mg
(a) omit from the column headed “Claimed Price”: 3.99 substitute: 4.22
Schedule 1, entry for Glimepiride in the form Tablet 4 mg
omit from the column headed “Claimed Price”: 4.51 substitute: 4.73
Schedule 1, entry for Hypromellose in the form Eye drops 3 mg per mL, 15 mL
omit from the column headed “Claimed Price”: 5.79 substitute: 6.84
Schedule 1, entry for Hypromellose with Carbomer 980 in the form Ocular lubricating gel 3 mg-2 mg per g, 10 g
omit from the column headed “Claimed Price”: 5.79 substitute: 6.84
Schedule 1, entry for Indapamide with Tablet containing indapamide hemihydrate 2.5 mg
omit from the column headed “Claimed Price”: 8.53 substitute: 10.16
Schedule 1, entry for Irbesartan in the form Tablet 75 mg [Brands: Avapro; Karvea]
omit from the column headed “Claimed Price”: 2.55 substitute: 3.11
Schedule 1, entry for Irbesartan in the form Tablet 150 mg [Brands: Avapro; Karvea]
omit from the column headed “Claimed Price”: 3.12 substitute: 3.67
Schedule 1, entry for Irbesartan in the form Tablet 300 mg [Brands: Avapro; Karvea]
omit from the column headed “Claimed Price”: 5.03 substitute: 5.59
Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 150 mg-12.5 mg [Brands: Avapro HCT 150/12.5;
Karvezide 150/12.5]omit from the column headed “Claimed Price”: 3.16 substitute: 3.95
Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-12.5 mg [Brands: Avapro HCT 300/12.5;
Karvezide 300/12.5]omit from the column headed “Claimed Price”: 5.02 substitute: 5.79
Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-25 mg [Brands: Avapro HCT 300/25;
Karvezide 300/25]omit from the column headed “Claimed Price”: 5.35 substitute: 6.15
Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Imdur Durule]
(a) omit from the column headed “Determined Price”: 3.22 substitute: 3.42
(b) omit from the column headed “Claimed Price”: 6.35 substitute: 6.56
Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Monodur 60 mg]
(a) omit from the column headed “Determined Price”: 3.22 substitute: 3.42
(b) omit from the column headed “Claimed Price”: 5.52 substitute: 5.73
Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 100 mg
(a) omit from the column headed “Determined Price”: 7.79 substitute: 12.32
(b) omit from the column headed “Claimed Price”: 11.05 substitute: 15.58
Schedule 1, after entry for Labetalol in the form Tablet containing labetalol hydrochloride 200 mg
insert in the columns in the order indicated:
| Lamivudine | Tablet 100 mg | Oral | Zeffix | 28 | 55.34 | 56.30 |
Schedule 1, entry for Lamotrigine in the form Tablet 5 mg
(a) omit from the column headed “Determined Price”: 3.60 substitute: 5.88
(b) omit from the column headed “Claimed Price”: 5.20 substitute: 7.48
Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| Oral | Levlen ED | 4 | 6.39 | 8.71 |
Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”: 5.71 substitute: 7.11
Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”: 7.22 substitute: 8.61
Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]
omit from the column headed “Claimed Price”: 5.71 substitute: 7.11
Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
omit from the column headed “Claimed Price”: 7.57 substitute: 8.97
Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 1 g
omit from the column headed “Claimed Price”: 7.22 substitute: 8.61
Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Brand: Betaloc]
omit from the column headed “Claimed Price”: 4.90 substitute: 5.26
Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Brand: Betaloc]
omit from the column headed “Claimed Price”: 5.40 substitute: 5.76
Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
substitute:
| Tablet 15 mg (orally disintegrating) | Oral | Avanza SolTab | 30 | 4.52 | 8.24 |
| Remeron SolTab | 30 | 4.52 | 8.24 |
Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
substitute:
| Tablet 30 mg (orally disintegrating) | Oral | Avanza SolTab | 30 | 6.02 | 9.74 |
| Remeron SolTab | 30 | 6.02 | 9.74 |
Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
substitute:
| Tablet 45 mg (orally disintegrating) | Oral | Avanza SolTab | 30 | 9.07 | 12.79 |
| Remeron SolTab | 30 | 9.07 | 12.79 |
Schedule 1, entry for Moclobemide in the form Tablet 150 mg
(a) omit from the column headed “Determined Price”: 5.16 substitute: 9.06
(b) omit from the column headed “Claimed Price”: 5.46 substitute: 9.36
Schedule 1, entry for Moclobemide in the form Tablet 300 mg
(a) omit from the column headed “Determined Price”: 9.93 substitute: 15.13
(b) omit from the column headed “Claimed Price”: 10.53 substitute: 15.73
Schedule 1, entry for Montelukast
omit from the column headed “Claimed Price”: 9.78 substitute: 10.36
Schedule 1, entry for Nizatidine
substitute:
| Nizatidine | Capsule 150 mg | Oral | Nizac | 60 | 9.71 | 11.60 |
| Tazac | 60 | 9.71 | 15.86 | |||
| Capsule 300 mg | Oral | Nizac | 30 | 9.71 | 11.60 | |
| Tazac | 30 | 9.71 | 15.86 |
Schedule 1, after entry for Omeprazole
insert:
| Ondansetron | Wafer 4 mg | Oral | Zofran Zydis | 4 | 4.17 | 6.96 |
| Zofran Zydis | 10 | - | 13.22 | |||
| Wafer 8 mg | Oral | Zofran Zydis | 4 | 6.54 | 9.33 | |
| Zofran Zydis | 10 | - | 19.14 |
Schedule 1, entry for Paroxetine
omit from the column headed “Claimed Price”: 5.45 substitute: 6.62
Schedule 1, entry for Perindopril in the form Tablet containing perindopril argine 2.5 mg
(a) omit from the column headed “Claimed Price” [Coversyl 2.5mg]: 3.20 substitute: 6.31
(b) omit
| PREXUM 2.5 | 30 | 1.70 | 3.20 |
Schedule 1, after entry for Perindopril in the form Tablet containing perindopril arginine 2.5 mg
insert:
| Tablet containing perindopril arginine 5 mg | Oral | Coversyl 5mg | 30 | 3.17 | 7.77 |
| Tablet containing perindopril arginine 10 mg | Oral | Coversyl 10mg | 30 | 4.85 | 9.45 |
Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine
(as besylate)omit from the column headed “Claimed Price”: 8.15 substitute: 8.77
Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 10 mg amlodipine
(as besylate)omit from the column headed “Claimed Price”: 8.99 substitute: 9.53
Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine
(as besylate)omit from the column headed “Claimed Price”: 9.79 substitute: 10.45
Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine
(as besylate)omit from the column headed “Claimed Price”: 10.61 substitute: 11.22
Schedule 1, after entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine
(as besylate)insert:
| Perindopril with indapamide | Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral | Coversyl Plus 5mg/1.25mg | 30 | 4.10 | 8.71 |
Schedule 1, after entry for Piroxicam in the form Dispersible tablet 20 mg
insert:
| Potassium chloride | Tablet 600 mg (sustained release) | Oral | Slow-K | 100 | 3.80 | 5.20 |
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
omit from the column headed “Claimed Price”: 2.68 substitute: 5.02
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
omit from the column headed “Claimed Price”: 3.69 substitute: 6.04
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
omit from the column headed “Claimed Price”: 5.25 substitute: 7.60
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
omit from the column headed “Claimed Price”: 7.54 substitute: 9.88
Schedule 1, entry for Prochlorperazine
omit from the column headed “Claimed Price”: 3.46 substitute: 3.80
Schedule 1, entry for Propranolol
substitute:
| Propranolol | Tablet containing propranolol hydrochloride 10 mg | Oral | Deralin 10 | 100 | 2.56 | 5.34 |
| Inderal | 100 | 2.56 | 6.05 | |||
| Tablet containing propranolol hydrochloride 40 mg | Oral | Deralin 40 | 100 | 2.81 | 5.59 | |
| Inderal | 100 | 2.81 | 6.30 |
Schedule 1, after entry for Quinapril in the form Tablet 20 mg (as hydrochloride)
insert:
| Rabeprazole | Tablet containing rabeprazole sodium 10 mg (enteric coated) | Oral | Pariet | 28 | 3.59 | 8.25 |
| Tablet containing rabeprazole sodium 20 mg (enteric coated) | Oral | Pariet | 30 | 3.59 | 8.25 |
Schedule 1, entry for Roxithromycin in the form Tablet 150 mg
(a) omit from the column headed “Determined Price”: 1.56 substitute: 2.31
(b) omit from the column headed “Claimed Price”: 3.07 substitute: 3.81
Schedule 1, entry for Roxithromycin in the form Tablet 300 mg
(a) omit from the column headed “Determined Price”: 1.56 substitute: 2.31
(b) omit from the column headed “Claimed Price”: 3.07 substitute: 3.81
Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
(a) omit from the column headed “Determined Price”: 2.99 substitute: 3.45
(b) omit from the column headed “Claimed Price”: 3.93 substitute: 4.63
Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]
omit from the column headed “Claimed Price”: 5.11 substitute: 6.75
Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]
omit from the column headed “Claimed Price”: 5.62 substitute: 7.27
Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]
omit from the column headed “Claimed Price”: 6.37 substitute: 8.01
Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]
omit from the column headed “Claimed Price”: 7.41 substitute: 12.31
Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg
omit from the column headed “Claimed Price”: 6.09 substitute: 7.99
Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg
omit from the column headed “Claimed Price”: 10.01 substitute: 11.90
Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 2]
omit from the column headed “Claimed Price”: 4.07 substitute: 4.87
Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 4]
omit from the column headed “Claimed Price”: 8.15 substitute: 9.75
Schedule 1, entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 2]
omit from the column headed “Claimed Price”: 4.07 substitute: 4.87
Schedule 1, entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 4]
omit from the column headed “Claimed Price”: 8.15 substitute: 9.75
Schedule 1, after entry for Sumatriptan
omit from the column headed“Listed drug”: isartan substitute: Telmisartan
Schedule 1, entry for Telmisartan in the form Tablet 40 mg
omit from the column headed “Claimed Price”: 3.62 substitute: 4.50
Schedule 1, entry for Telmisartan in the form Tablet 80 mg
omit from the column headed “Claimed Price”: 8.36 substitute: 9.24
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-5 mg (as besylate)
omit from the column headed “Claimed Price”: 4.64 substitute: 5.93
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-10 mg (as besylate)
omit from the column headed “Claimed Price”: 5.39 substitute: 6.64
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-5 mg (as besylate)
omit from the column headed “Claimed Price”: 9.33 substitute: 10.67
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-10 mg (as besylate)
omit from the column headed “Claimed Price”: 10.06 substitute: 11.38
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 40 mg-12.5 mg
omit from the column headed “Claimed Price”: 4.91 substitute: 5.67
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-12.5 mg
omit from the column headed “Claimed Price”: 9.82 substitute: 10.65
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-25 mg
omit from the column headed “Claimed Price”: 11.17 substitute: 11.94
Schedule 1, entry for Temazepam in the form Tablet 10 mg
(a) omit from the column headed “Determined Price”: 0.75 substitute: 1.00
(b) omit from the column headed “Claimed Price”: 3.99 substitute: 4.24
Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
(a) omit from the column headed “Determined Price”: 0.93 substitute: 1.86
(b) omit from the column headed “Claimed Price”: 3.18 substitute: 4.11
Schedule 1, entry for Trimethoprim
omit from the column headed “Claimed Price”: 3.12 substitute: 5.00
Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 5.47 substitute: 7.32
Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg
omit from the column headed “Claimed Price”: 5.43 substitute: 7.31
Schedule 1, after entry for Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg
insert:
| Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | Valtrex | 10 | 6.37 | 7.89 |
| Valtrex | 30 | 22.14 | ||||
| Valtrex | 42 | 29.78 | ||||
| Valtrex | 100 | 64.33 |
Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
omit from the column headed “Claimed Price”: 6.25 substitute: 6.39
Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
omit from the column headed “Claimed Price”: 11.60 substitute: 11.74
Schedule 2, omit entry for Olmesartan
0
0
0